PASG – passage bio, inc. (US:NASDAQ)

News

Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
Passage Bio to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Passage Bio to Participate in Upcoming Investor Conferences
Passage Bio (NASDAQ:PASG) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com